4126.TWO · PAHSCO
Taiwan · RS rating 54 · As of 2026-10-08
| Price | 77.50 TWD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 44 / 64 / 41 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 27 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +7.0% |
| Sales growth Q/Q | +3.7% |
| Distance from 52-week high | +13.5% |
| Market cap (USD) | $177.3M |